ICH GCP - EU Clinical trials Registry

EudraCT Number: 2004-000784-97

Sponsor Protocol Number: SB-275833/032

Start Date: 2004-02-16

Sponsor Name: GlaxoSmithKline Research & Development Ltd

Full Title: A Randomized, Double-blind, Double-Dummy, Multicenter, Non-inferiority Phase III Study to Assess the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily, versus Oral Cephalexi...

Medical condition: Secondarily-Infected Dermatoses

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10012470		PT

Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2006-004751-38

Sponsor Protocol Number: om 174

Start Date: 2004-02-11

Sponsor Name: OSPEDALE ONCOLOGICO DI BARI

Full Title: Vaccine with dendritic cells pulsed tumoral cell line or with autologue tumor in patients with kidney carcinoma

Medical condition: kidney carcinoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10038415		PT

Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2006-003752-38

Sponsor Protocol Number: om 169

Start Date: 2003-12-09

Sponsor Name: OSPEDALE ONCOLOGICO DI BARI

Full Title: A phase II study of Capecitabine in combination with oral vinorelbine in advanced Breast Cancer

Medical condition: advancer breast carcinoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10006279	Breast neoplasm	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2005-001055-38

Sponsor Protocol Number: IELSG20

Start Date: 2003-11-28

Sponsor Name: INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP IELSG

Full Title: RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE, ALONE OR ASSOCIATED WITH HIGHDOSE CYTARABINE, FOLLOWED BY RESPONSE- AND AGE-TAILORED RADIOTHERAPY FOR IMMUNOCOMPETENT ...

Medical condition: primary chemotherapy of primary central nervous system lymphoma with high dose cytarabine plus methotrexate

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10012818		PT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-002113-36

Sponsor Protocol Number: EORTC 62012

Start Date: 2003-05-20

Sponsor Name: European Organisation for the Research and Treatment of Cancer

Full Title: Randomised trial of single agent doxorubicin versus doxorubicin plus ifosfamide in the first line treatment of advanced or metastatic soft tissue sarcoma

Medical condition: Locally advanced or metastatic soft tissue sarcoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10041299		HLGT

Population Age: Adults

Gender: Male, Female

Trial protocol: SK (Completed)

Trial results: View results

EudraCT Number: 2006-003746-42

Sponsor Protocol Number: om 145

Start Date: 2003-02-11

Sponsor Name: OSPEDALE ONCOLOGICO DI BARI

Full Title: Immunotherapy vs immuno-chemotherapy in patients with metastatic kidney carcinoma

Medical condition: metastatic kidney carcinoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10038408		HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-002737-21

Sponsor Protocol Number: om 2002

Start Date: 2002-09-10

Sponsor Name: OSPEDALE ONCOLOGICO DI BARI

Full Title: A randomized phase II study in the advanced or metastatic transitional cell urotelium carcinoma between Gemcitabine + Cisplatin e Gemcitabine + Cisplatino + Taxolo

Medical condition: Advanced transitional cell bladder carcinoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10029104	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	SOC

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-002053-69

Sponsor Protocol Number: 3068A1-301-WW

Start Date: 2002-08-13

Sponsor Name: Wyeth Research Division of Wyeth Pharmaceuticals Inc.

Full Title: FRACTURE INCIDENCE REDUCTION AND SAFETY OF TSE-424 (BAZEDOXIFENE ACETATE) COMPARED TO PLACEBO AND RALOXIFENE IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN

Medical condition: Reduction of new vertebral fractures in osteoporotic postmenopausal women- Osteoporosis

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10031282	Osteoporosis	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: HU (Completed) BG (Completed)

Trial results: View results

EudraCT Number: 2006-004084-66

Sponsor Protocol Number: om 112

Start Date: 2002-07-09

Sponsor Name: OSPEDALE ONCOLOGICO DI BARI

Full Title: A phase II study on the efficacy and safety of topotecan in the treatment of patients with brain metastases

Medical condition: Brain metastases

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10061287		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2005-002385-11

Sponsor Protocol Number: BIG01−01/BO16348B

Start Date: 2002-05-16

Sponsor Name: F. HOFFMANN - LA ROCHE LTD.

Full Title: -

Medical condition: -

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004864	10006173	Breast adenocarcinoma	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: IT (Completed)

Trial results: (No results available)

Neueste Versuche

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen